IL-17 is a cytokine that is thought to contribute to the development of IBD and has strong proinflammatory activity (Magyari et al., 2014), which is significantly elevated in patients with active ulcerative colitis and Crohn’s disease (Seiderer et al., 2008). Here, IL17A is linked to inflammatory bowel disease.